Business Description
Smith & Nephew PLC
NAICS : 339113
ISIN : GB0009223206
Description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | 3.35 | |||||
| Interest Coverage | 4.09 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.98 | |||||
| Beneish M-Score | -2.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.1 | |||||
| 3-Year EBITDA Growth Rate | -10.5 | |||||
| 3-Year EPS without NRI Growth Rate | -26.3 | |||||
| 3-Year FCF Growth Rate | -46.2 | |||||
| 3-Year Book Growth Rate | 3.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 30.29 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.06 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.07 | |||||
| 9-Day RSI | 26.94 | |||||
| 14-Day RSI | 29.34 | |||||
| 6-1 Month Momentum % | -5.12 | |||||
| 12-1 Month Momentum % | 1.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.19 | |||||
| Quick Ratio | 0.83 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 502.53 | |||||
| Days Sales Outstanding | 80.07 | |||||
| Days Payable | 228.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.06 | |||||
| Dividend Payout Ratio | 1.49 | |||||
| 3-Year Dividend Growth Rate | 4.6 | |||||
| Forward Dividend Yield % | 2.9 | |||||
| 5-Year Yield-on-Cost % | 3.81 | |||||
| 3-Year Average Share Buyback Ratio | 0.4 | |||||
| Shareholder Yield % | 2.89 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.04 | |||||
| Operating Margin % | 9.01 | |||||
| Net Margin % | 4.03 | |||||
| ROE % | 4.06 | |||||
| ROA % | 2.16 | |||||
| ROIC % | 5.16 | |||||
| ROC (Joel Greenblatt) % | 10.44 | |||||
| ROCE % | 4.39 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 49.88 | |||||
| Forward PE Ratio | 12.85 | |||||
| PE Ratio without NRI | 49.88 | |||||
| Shiller PE Ratio | 19.01 | |||||
| PS Ratio | 2.02 | |||||
| PB Ratio | 2.11 | |||||
| Price-to-Tangible-Book | 10.96 | |||||
| Price-to-Free-Cash-Flow | 433.74 | |||||
| Price-to-Operating-Cash-Flow | 28.58 | |||||
| EV-to-EBIT | 38.42 | |||||
| EV-to-Forward-EBIT | 15.31 | |||||
| EV-to-EBITDA | 15.37 | |||||
| EV-to-Forward-EBITDA | 9.46 | |||||
| EV-to-Revenue | 2.56 | |||||
| EV-to-Forward-Revenue | 2.37 | |||||
| EV-to-FCF | 574.15 | |||||
| Price-to-Projected-FCF | 1.21 | |||||
| Price-to-Median-PS-Value | 0.6 | |||||
| Price-to-Graham-Number | 4.94 | |||||
| Earnings Yield (Greenblatt) % | 2.6 | |||||
| Forward Rate of Return (Yacktman) % | -2.59 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Smith & Nephew PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 4,312.243 | ||
| EPS (TTM) (£) | 0.2 | ||
| Beta | 0.78 | ||
| Volatility % | 26.58 | ||
| 14-Day RSI | 29.34 | ||
| 14-Day ATR (£) | 0.190738 | ||
| 20-Day SMA (£) | 10.4378 | ||
| 12-1 Month Momentum % | 1.33 | ||
| 52-Week Range (£) | 9.592 - 13.1675 | ||
| Shares Outstanding (Mil) | 873.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Smith & Nephew PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Smith & Nephew PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Smith & Nephew PLC Frequently Asked Questions
What is Smith & Nephew PLC(LSE:SN.)'s stock price today?
The current price of LSE:SN. is £9.98. The 52 week high of LSE:SN. is £13.17 and 52 week low is £9.59.
When is next earnings date of Smith & Nephew PLC(LSE:SN.)?
The next earnings date of Smith & Nephew PLC(LSE:SN.) is 2024-02-21 Est..
Does Smith & Nephew PLC(LSE:SN.) pay dividends? If so, how much?
The Dividend Yield %  of Smith & Nephew PLC(LSE:SN.) is 3.06% (As of Today), Highest Dividend Payout Ratio of Smith & Nephew PLC(LSE:SN.) was 1.52. The lowest was 0.35. And the median was 0.52. The  Forward Dividend Yield % of Smith & Nephew PLC(LSE:SN.) is 2.9%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers